Regeneron Pharmaceuticals, inc.
Proposal 1a.
Election of Director: N. Anthony Coles, M.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1b.
Election of Director: Kathryn Guarini, Ph.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1c.
Election of Director: Arthur F. Ryan
Caisse vote:
Against
Applicable policy or principle:
PDV_01
Proposal 1d.
Election of Director: David P. Schenkein, M.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1e.
Election of Director: George L. Sing
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 2.
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 3.
Proposal to approve, on an advisory basis, executive compensation.
Caisse vote:
Against
Applicable policy or principle:
PDV_01
Proposal 4.
Non-binding shareholder proposal requesting simple majority voting requirements, if properly presented.
Caisse vote:
For
Applicable policy or principle:
PDV_01